INS and obesity due to melanocortin 4 receptor deficiency: The study cohort included 57 lean and healthy subjects (58.8%), 15 subjects with class 1 obesity (15.5%; BMI 33.7 ± 1.2 kg/m2), and 25 persons with T1D on insulin replacement who were otherwise healthy (25.8%).